VALEANT PHARMACEUTICALS INTL

VRX stock holders 13F

5 superinvestors reported owning VRX (Common Stock) according to the gurus' 2016 Q3 reports.

Top 5 gurus who own (VRX) VALEANT PHARMACEUTICALS INTL

The 5 super investors (holders) owning VRX (by the percentage (%) of portfolio) are Francis Chou - Chou Associates Management (13.40%), Bill Ackman - Pershing Square Capital Management (9.79%), Bill Miller - Miller Value Partners (3.21%), Jeffrey Ubben - ValueAct Holdings (3.20%) and Ravenel Boykin Curry IV - Eagle Capital Management (0.00%) as of their 2016 Q3 reports.

To check the latest activities of the top VRX shareholders between value investors, please click on the "Activity" tab.

To see the historical data of VRX's holders please click on the "2016 Q3" dropdown menu and select the date.

# of holders: 5
Period: 2016 Q3
Type: Common Stock
History
Name
Company
% of
Portfolio
Shares*
Price*
Value
% (shares)
Activity
% change to
Portfolio
Bill Ackman
Pershing Square Capital Management
9.79%
21,591,122
$24.55
$530,062,000
Bill Miller
Miller Value Partners
3.21%
2,291,400
$24.55
$56,254,000
+14.21% (+285,100)
+0.40%
Francis Chou
Chou Associates Management
13.40%
1,446,843
$24.55
$35,520,000
Jeffrey Ubben
ValueAct Holdings
3.20%
12,970,035
$24.55
$318,414,285
Ravenel Boykin Curry IV
Eagle Capital Management
0.00%
28,278
$24.56
$694,520
-6.72% (-2,037)
-0.00%
AVG reported hold price*: $24.55

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.